SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Company declared distributions to stockholders across multiple share classes (Class E, I, A-I, A-II, and T common stock) with a gross per-share amount of $0.04326 and varying net amounts after fees, with a record date of July 31, 2026 and payment date of approximately August 10, 2026.
View raw filing on EDGAR →Heritage Global's Board authorized a strategic plan to wind down the Specialty Lending segment (Heritage Global Capital LLC), a material business unit, with expected cash expenditures consisting primarily of employee-related costs and professional services expenses, along with a material non-cash impairment charge.
View raw filing on EDGAR →The filing discloses a declaration of distributions to stockholders across seven classes of common stock, with specific per-share amounts ranging from $0.0749 to $0.1124 (gross), payable on or about August 20, 2026. This is a routine but material dividend distribution event typical of real estate investment trusts (REITs) and closed-end funds, disclosed under Item 7.01 (Regulation FD Disclosure) as a formal announcement to the market.
View raw filing on EDGAR →PowerCompute entered into a bridge loan transaction on July 27, 2026, borrowing $18 million from Arch Lending through two Promissory Notes to fund repayment of existing indebtedness, and extended an existing $1.125 million loan with Brown Family Enterprises.
View raw filing on EDGAR →Newell Brands entered into a new $800 million asset-based revolving credit facility with JPMorgan Chase Bank on July 30, 2026, and immediately drew $490 million to refinance its existing revolving facility.
View raw filing on EDGAR →Newell Brands terminated a material definitive agreement, signaling a material change in transaction status that affects the registrant's strategic position and financial obligations.
View raw filing on EDGAR →The filing discloses a declared monthly distribution to shareholders of BlackRock Monticello Debt Real Estate Investment Trust for July 2026, with specific per-share amounts ($0.1927 gross) across three share classes, payable on or about August 20, 2026. This is a routine but material dividend distribution typical of REITs, which are required to distribute substantially all taxable income to shareholders.
View raw filing on EDGAR →The filing discloses a dividend declaration and issuance by the Board on July 28, 2026, consisting of 281,344 Series A Preferred Shares and 338,240 Series C Preferred Shares issued as dividends in kind to existing preferred shareholders. While filed under Item 3.02 (Unregistered Sales), the substance is a dividend distribution of preferred stock, which materially affects shareholder equity and capital structure. The Section 4(a)(2) exemption is cited for the issuance mechanics, but the primary event is the dividend declaration and distribution.
View raw filing on EDGAR →Armada Acquisition Corp. II entered into an unsecured promissory note with Arrington XRP Capital Fund, LP on July 27, 2026, and borrowed $135,000 on July 31, 2026. The note carries short-term Applicable Federal Rate interest, maturity conditions tied to the Business Combination Agreement, and prepayment rights, representing a material new direct financial obligation for the SPAC's working capital needs.
View raw filing on EDGAR →This 8-K Item 8.01 discloses a material merger transaction between AvalonBay Communities, Inc. and Equity Residential, with an Agreement and Plan of Merger entered into on May 20, 2026. The filing provides unaudited pro forma condensed consolidated financial statements reflecting the proposed combination, which is a classic material acquisition/change of control event. The merger is expected to close in the second half of 2026, with legacy AvalonBay stockholders owning approximately 51% and legacy Equity Residential shareholders approximately 49% of the combined company post-closing.
View raw filing on EDGAR →Universal Logistics Holdings disclosed second quarter 2026 financial results via press release dated July 31, 2026, reporting operating revenues of $379.3 million, operating income of $45.1 million, net income of $26.2 million, and GAAP EPS of $0.99 per share for the thirteen and twenty-six week periods ended July 4, 2026.
View raw filing on EDGAR →The Company's board of directors declared a cash dividend of $0.105 per share of common stock, payable October 1, 2026 to shareholders of record on September 1, 2026.
View raw filing on EDGAR →Ashland entered into the Fifth Amendment to its Receivables Purchase Agreement on July 30, 2026, extending its accounts receivable securitization facility through July 28, 2028 with commitments of up to $70 million. This amendment creates or modifies a direct financial obligation that functions as a source of liquidity and financing.
View raw filing on EDGAR →Eagle Materials held its Annual Meeting of Stockholders on July 30, 2026, at which shareholders elected three Class II directors (Margot L. Carter, Michael R. Nicolais, and Mary P. Ricciardello), approved an advisory say-on-pay resolution, approved two charter amendments (board declassification and stockholder special meeting rights), and approved Ernst & Young LLP as independent auditors.
View raw filing on EDGAR →FTI Consulting issued a press release on July 30, 2026 announcing financial results for the second quarter and six months ended June 30, 2026, reporting record Q2 revenues of $993.5 million (up 5.3% YoY), net income of $57.8 million, EPS of $1.99, and Adjusted EPS of $2.16, along with updated full-year 2026 guidance and details on capital allocation activities including $390.9 million in share repurchases.
View raw filing on EDGAR →Galera completed a private placement of Series C Non-Voting Convertible Preferred Stock to qualified institutional buyers and accredited investors, raising approximately $350.0 million in gross proceeds under Section 4(a)(2) exemption from registration.
View raw filing on EDGAR →Galera declared a distribution of contingent value rights (CVRs) to holders of common stock as of July 31, 2026, with distribution expected August 6, 2026, representing contingent cash payments tied to future asset dispositions.
View raw filing on EDGAR →Synchrony Financial entered into an underwriting agreement on July 28, 2026 to issue $600 million of 5.450% Fixed-to-Floating Rate Senior Notes due 2030 and $500 million of 6.276% Fixed-to-Floating Rate Senior Notes due 2037, totaling $1.1 billion in new debt. This is a material creation of direct financial obligations disclosed under Item 8.01 (Other Events), representing a significant capital-raising transaction that would affect a reasonable investor's assessment of the company's leverage and financial position.
View raw filing on EDGAR →Item 5.07 discloses the results of Seer's 2026 Annual Meeting of Stockholders held on July 28, 2026, including voting outcomes on four matters: (1) election of seven directors with detailed vote tallies for each nominee, (2) ratification of Deloitte & Touche LLP as independent auditor, (3) non-binding advisory vote on named executive officer compensation, and (4) ratification of the Tax Benefit Preservation Plan (which failed). The filing presents the formal voting results tabulated by the independent Inspector of Election, which is the core disclosure required under Item 5.07 for shareholder meeting outcomes.
View raw filing on EDGAR →The filing discloses conditional appointments of three key executives—Brigette Roberts as CEO, John Militello as CFO, and Keith Fandrick as COO—effective upon stockholder approval of acquisition-related proposals at the September 25, 2026 Special Meeting. While the section also mentions conditional resignations of the current CEO and COO, the Board's affirmative action on July 29, 2026 was to approve these three appointments, making the appointment the principal disclosed action. The appointments are material as they represent a complete change in the executive leadership team contingent on stockholder approval of the Orphai acquisition.
View raw filing on EDGAR →Armin Zerza's departure as Chief Financial Officer and Chief Operating Officer is the primary disclosed event. While the filing also announces two appointments (Louis Dickler as Acting CFO and Tom Corson as COO), the central action triggering the Item 5.02 disclosure is Zerza's stepping down "for personal reasons" effective July 31, 2026. The departure of a dual CFO/COO is material to investors assessing financial and operational leadership continuity.
View raw filing on EDGAR →The filing announces the Company's failure to consummate a business combination before the Completion Window expires on August 12, 2026, triggering mandatory liquidation, redemption of public shares at ~$11.47/share, and delisting from Nasdaq. The Company explicitly states "The last day that the Company's securities will trade on The Nasdaq Stock Market LLC ("Nasdaq") will be August 12, 2026" and intends to file Form 15 to suspend reporting obligations. While this is a terminal event for a SPAC, the most salient disclosure is the imminent delisting and loss of public trading status, which is material to all shareholders.
View raw filing on EDGAR →BigBear.ai entered into an Open Market Sale Agreement with Jefferies LLC to sell up to 100,000,000 shares of common stock through an at-the-market offering under a Form S-3 registration statement. This is a dilutive equity issuance that could substantially increase share count and is material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →Avista Corporation issued a press release on August 3, 2026 reporting Q2 2026 financial results, including net income of $35 million and diluted EPS of $0.43, along with confirmation of 2026 utility earnings guidance of $2.52–$2.72 per share.
View raw filing on EDGAR →The filing discloses adoption of a new Executive Severance Policy applicable to the CEO and other executives, and a separate Severance Agreement with Megan Wynne specifying severance benefits upon qualifying termination events. These are compensatory arrangements for named executives under Item 5.02(e), establishing material financial obligations triggered by employment termination. While severance agreements can sometimes signal an impending departure, the prose centers on the *arrangement itself* rather than an actual departure or appointment, making exec_compensation the most precise classification.
View raw filing on EDGAR →Ward Lyke, Jr., Vice President, Chief Financial Officer, and Treasurer, is departing the Company effective September 25, 2026, pursuant to a transition agreement dated July 30, 2026. While the disclosure also mentions separation benefits (six weeks of base salary) and the appointment of Kevin Guptar as Principal Financial Officer, the principal disclosed action is Mr. Lyke's departure from a named executive officer role. The departure of a CFO is material to investors' assessment of the registrant's financial leadership and continuity.
View raw filing on EDGAR →The filing discloses the appointment of Stephen P. Ribaudo as Executive Vice President and Chief Operating Officer effective September 1, 2026, along with detailed compensation arrangements including base salary of $670,000, equity grants totaling at least $1,794,000 for the first year, and a $1,000,000 make-whole RSU award. This is a material C-suite appointment that would affect investor assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →The 6-K discloses results of an Extraordinary General Meeting held on July 31, 2026, where shareholders voted on and approved material resolutions including an 8-for-1 share consolidation, reclassification of shares into Class A and Class B with differential voting rights (1 vote vs. 50 votes per share), and adoption of amended memorandum and articles of association. The voting results are explicitly presented with vote counts for each resolution. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the capital structure changes are material to investors.
View raw filing on EDGAR →This Item 8.01 disclosure concerns the contingent value rights (CVRs) structure established in connection with Jasper Therapeutics' acquisition of Kira Pharmaceuticals, which closed on July 16, 2026. The filing confirms the record date for CVR eligibility and describes the $30 million milestone payment contingent on FDA Priority Review Voucher issuance for briquilimab by December 31, 2028. While technically an "Other Events" item, the substance is a material acquisition completion with contingent consideration terms, making this a follow-up disclosure to the M&A activity previously reported on the Prior Form 8-K filed July 16, 2026.
View raw filing on EDGAR →The 6-K discloses the issuance of $125,000,000 aggregate principal amount of 7.50% Senior Unsecured Convertible Notes due 2031 on July 17, 2026. This is a material creation of a direct financial obligation. Although the notes are convertible (which could suggest a dilutive element), the primary event disclosed is the debt issuance itself, and the filing's core purpose is to announce the notes and establish registration rights for resale. The convertible feature is secondary to the debt obligation being created.
View raw filing on EDGAR →The 6-K discloses that NewGen issued Class A shares in connection with strategic share purchase agreements to acquire a 3% equity interest in K25.ai. The issuance increased total outstanding Class A shares to 5,919,948, representing a dilutive equity issuance. While the filing does not explicitly state the shares were unregistered, the context of a strategic acquisition agreement and the absence of registration details suggest this is a private placement or similar dilutive issuance material to shareholders.
View raw filing on EDGAR →The press release announces the appointment of Dean Martin as SVP, Head of the Automotive Business Unit, effective September 1, 2026, succeeding Adar Segal who is stepping down. This is a clear executive appointment of a named officer to a senior leadership role overseeing a key business unit. The disclosure emphasizes Martin's 25+ years of automotive industry experience and his role in driving the company's automotive growth strategy, making this material to investors assessing management quality and execution capability.
View raw filing on EDGAR →This press release announces positive clinical trial results from a Phase 2 study of intranasal foralumab in Multiple System Atrophy patients, specifically quantitative PET imaging data showing reductions in brain inflammation (up to 34% SUV reduction) in the third patient to complete dosing. The disclosure is a clinical milestone announcement for the company's lead candidate, demonstrating reproducible biological activity across three patients. While not a traditional earnings release or discrete M&A/governance event, this represents a material operational/clinical development that would affect a reasonable investor's assessment of the company's pipeline progress and therapeutic potential.
View raw filing on EDGAR →TOP Financial Group Ltd completed a 1-for-5 share consolidation effective August 3, 2026, approved by the board on July 20, 2026 and authorized by shareholders at an extraordinary general meeting on May 27, 2026. The consolidation reduced Class A shares from approximately 608.5 million to 121.7 million and Class B shares from 10 million to approximately 2 million, with corresponding adjustments to par value and authorized capital reflected in amendments to the Company's Memorandum and Articles of Association.
View raw filing on EDGAR →The 6-K discloses entry into an acquisition agreement on July 30, 2026, whereby ATIF Holdings agreed to acquire all equity interests of GoldCoin Labs Limited for $20 million in consideration (2,815,005 ordinary shares). The filing explicitly describes the acquisition structure, consideration, closing conditions, fairness opinion, and strategic rationale. This is a material acquisition transaction that would significantly affect investor assessment of the company's strategic direction and capital deployment.
View raw filing on EDGAR →Oxford Square Capital Corp. issued a press release on July 31, 2026 announcing its financial results for the second quarter ended June 30, 2026, including net asset value per share of $1.29, net investment income of $5.1 million ($0.05 per share), total investment income of $9.4 million, and total expenses of $4.3 million.
View raw filing on EDGAR →This exhibit is explicitly titled "EARNING RELEASE DATED JULY 31, 2026, ANNOUNCING ITS FINANCIAL RESULTS FOR THE FISCAL YEAR ENDED MARCH 31, 2026" and contains a press release announcing full-year financial results including revenue ($132.2M, up 10.2%), gross profit, net loss ($1.25M vs. prior year net income of $10.2M), and detailed consolidated financial statements. The shift from profitability to loss, combined with strategic M&A activity (Allright acquisition and retail divestiture) disclosed within the results, makes this material to investors assessing the company's financial condition and operational transformation.
View raw filing on EDGAR →WF Holding entered into a standby equity purchase agreement on July 30, 2026, committing to issue up to $30 million of ordinary shares to an institutional investor, plus an immediate issuance of 750,000 shares as consideration. This is a classic PIPE-like arrangement (private placement of equity) where the company retains discretion over timing and amount but has committed to a substantial equity facility. The dilutive nature and capital-raising purpose are unmistakable, and the $30 million commitment amount is material to a small-cap issuer.
View raw filing on EDGAR →Columbus Acquisition Corp received notice from Nasdaq on July 28, 2026 that it failed to meet Listing Rule 5450(a)(2) (the "Minimum Holders Rule") as of May 22, 2026. Although Nasdaq granted an extension through November 18, 2026 to regain compliance, the company remains at risk of delisting if it cannot satisfy the minimum holders requirement by that deadline. This is a material disclosure of delisting risk under Item 3.01.
View raw filing on EDGAR →The press release announces a significant sales blanket agreement worth approximately RMB 1.6 billion with Shandong Yulong Petrochemical Company for supply of pipeline fittings to a major refining and chemical project. This is a material contract award that would affect a reasonable investor's assessment of the company's revenue prospects and market position, but it does not fit the specific event types (e.g., ma_activity, debt_issuance, earnings_release). It is clearly an operational/commercial milestone—a major customer contract—rather than a discrete financial event, governance change, or existential matter.
View raw filing on EDGAR →NewcelX announced a private placement of 347,134 common shares and warrants at $4.033 per share (20% premium to market), raising $1.4 million in unregistered equity securities under Section 4(a)(2) and Regulation D. This is a classic dilutive equity issuance by a clinical-stage biopharmaceutical company raising capital, material to investors assessing ownership dilution and the company's capital structure.
View raw filing on EDGAR →RBC Bearings issued a press release on July 31, 2026, announcing financial results for the first quarter of fiscal 2027 ended June 27, 2026. The disclosure includes detailed quarterly financial highlights (net sales of $519.5 million, gross margin of 47.7%, net income of $101.5 million, diluted EPS of $3.20), segment performance data, and forward guidance for Q2 fiscal 2027. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1.
View raw filing on EDGAR →This Item 2.02 discloses SB Financial Group's second quarter 2026 financial results through a conference call transcript. The filing explicitly states the company "hosted a conference call and webcast to discuss its financial results for the second quarter ending June 30, 2026," with the transcript furnished as Exhibit 99.1. The disclosure includes detailed financial metrics (net income of $4.5 million, diluted EPS of $0.72, loan balances of $1.19 billion, deposits of $1.39 billion) and operational performance commentary, which is characteristic of an earnings release disclosure under Item 2.02.
View raw filing on EDGAR →This is a straightforward earnings release disclosing SB Financial Group's second quarter 2026 financial results. The filing explicitly states that on July 23, 2026, the Company "issued a news release reporting financial results for the second quarter 2026," with the full press release furnished as Exhibit 99.1. The exhibit contains detailed quarterly earnings data including net income of $4.5 million, diluted EPS of $0.72, and comprehensive balance sheet and operational metrics—all hallmarks of a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →OSR Health disclosed Nasdaq's verbal communication confirming that its Shareholder Loyalty CVR program will not trigger mechanical price adjustments to the common stock. This is a material operational/strategic disclosure regarding the mechanics and treatment of a shareholder loyalty program, but does not fit neatly into any specific event category. The disclosure clarifies an important structural question about the CVR program's implementation and provides shareholders with clarity on eligibility and record dates, making it material to investors evaluating the program's value proposition.
View raw filing on EDGAR →The 6-K discloses the results of the 2026 Annual General Meeting held on July 29, 2026, with detailed voting tallies for 11 proposals including director re-appointments, auditor ratification, share subdivision, name change to "Biddance AI Systems, Inc," and migration from Cayman Islands to British Virgin Islands. These results are material to investors as they reflect shareholder approval of significant corporate governance and structural changes.
View raw filing on EDGAR →The 6-K discloses the completion of an acquisition of Best Praise International Limited on June 30, 2026, pursuant to a Share Purchase Agreement dated June 17, 2026. The Company acquired 100% of the Target's issued shares in exchange for 4,376,552 Class A ordinary shares, representing a material change of control transaction. The Target holds five patents in pharmaceutical compounds and drug delivery technologies, making this a material acquisition of intellectual property assets.
View raw filing on EDGAR →INmune Bio received approximately $4.6 million in combined R&D cash rebates from Australia ($4.2M) and the United Kingdom ($0.4M) through government incentive programs. The company explicitly states these "non-dilutive" proceeds "strengthen our financial position" and "extend our runway," and notes that the combined rebates exceeded net cash used in operating activities during Q2. This is a material financial event affecting the company's liquidity and cash runway, but does not fit a specific named category—it is neither a debt issuance, dividend distribution, nor impairment, making it appropriately classified as financial_other.
View raw filing on EDGAR →The Company increased the maximum aggregate offering price under an At The Market (ATM) offering agreement by $5,257,000 in additional common stock, with approximately $13.6 million already sold to date. ATM offerings are classic dilutive equity issuances used by smaller-cap companies to raise capital, and the magnitude here (combined ~$18.8 million) is material to a company of this size.
View raw filing on EDGAR →The Company received formal notice from Nasdaq on July 29, 2026 that it has "regained compliance" with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), and that "this matter is now closed." This disclosure directly addresses a delisting risk — the prior non-compliance with the bid price rule that threatened continued listing. The resolution of this compliance deficiency is material to investors assessing the registrant's exchange listing status.
View raw filing on EDGAR →